Association in Biological Technology

American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification

BETHESDA, Md., July 15 /PRNewswire/ -- The American Medical Informatics Association (AMIA) announced today that it had submitted additional written comments to the Office of the National Coordinator (ONC) and the HIT Policy Committee about meaningful use and electronic health record...

CutisPharma, Inc. Receives Verified Accreditation for Wholesale Distributors from the National Association of Boards of Pharmacy for Woburn Facility

Accreditation is designed to preserve the safety and integrity of the pharmaceutical supply chain WOBURN, Mass., June 23 /PRNewswire/ -- CutisPharma, Inc. announced today that it has received Verified Accredited Wholesale Distributors (VAWD) accreditation from the National Association of Boar...

MedNet Solutions to Introduce New EDC/eClinical Technologies at the 2009 Drug Information Association Annual Meeting

MINNETONKA, Minn., June 11 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, will unveil a variety of exciting new and enhanced eClinical technologies at the upcoming Drug Information Association (DIA) Annual Me...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

DUROS(R) continuous delivery of exenatide produces impressive reductions in fasting plasma glucose, HbA1c and body weight during 28-day treatment NEW ORLEANS, June 8 /PRNewswire/ -- Intarcia Therapeutics, Inc. today presented results from the first clinical study of ITCA 650 (DUROS(R) continu...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

PRINCETON, N.J., June 8 /PRNewswire/ -- Celator Pharmaceuticals today announced that new clinical and preclinical data demonstrating the extended therapeutic bioavailability and tumor cell selectivity of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in leukemia were presented at the 14th Co...

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

SAN DIEGO , June 6 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced positive secondary findings from the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltre...

VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation

Preclinical Data Reported by Roche at 69th Scientific Sessions SAN FRANCISCO, June 4 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced toda...

PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting

BOSTON, June 3 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association (DIA) 45th Annual Meeting, being held from June 21 - 25, 2009 ...

Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ) a biopharmaceutical company focused on the treatment of obesity, today announced the schedule of its upcoming Contrave(R) (naltrexone sustained release (SR)/bupropion SR) presentations taking place at the ...

Drug Information Association Launches New 45th Annual Meeting Online

The Drug Information Association (DIA) today announced its new 45th Annual Meeting Online. For the first time ever, DIA now offers live online content from its Annual Meeting. Horsham, PA (Vocus) May 28, 2009 -- The Drug Information Association (DIA) today announced i...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

First clinical study evaluating DUROS(R) continuous delivery of exenatide for the treatment of type 2 diabetes HAYWARD, Calif., May 27 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced it will present clinical data from a phase 1b study of ITCA 650 (DUROS(R) continuous delivery of e...

Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care

SILVER SPRING, Md., BOSTON and SOUTH SAN FRANCISCO, Calif., May 18 /PRNewswire/ -- The Pulmonary Hypertension Association (PHA), Tufts Medical Center, and Actelion Pharmaceuticals US, Inc., today announced Dr. Nicholas Hill of Tufts Medical Center as the recipient of the 2009 PHA Award of Excellen...

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

ROCKVILLE, Md., May 14 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today that it will present posters on its newly approved atypical antipsychotic, Fanapt(TM) (iloperidone), at the 162nd American Psychiatric Association (APA) annual meeting in San Francisco, Ca...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

MINNEAPOLIS, May 7 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced participation in the upcoming 89th Annual Meeting of the American Association for Thoracic Surgeons (AATS) being he...

Ocera Therapeutics Presents Data on AST-120 in Patients With Hepatic Encephalopathy at the European Association for the Study of Liver Disease Annual Meeting

The Company also Initiates the Phase 2b ASTUTE Clinical Trial for Mild Hepatic Encephalopathy SAN DIEGO, April 28 /PRNewswire/ -- Ocera Therapeutics, Inc., a privately held biopharmaceutical company, announced that data from its phase 2 study of AST-120 for the treatment of patients with low-...

Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences

-Testimony To Legislature Calls For Rejection Of Legislation That Will Cost Vermonters Current And Future Jobs- MONTPELIER, Vt., April 24 /PRNewswire/ -- In testimony to the Legislature and a full page ad in today's Rutland Herald, the region's largest biotechnology association warned that a ...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

CAMBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported data from its three hepatitis C development programs being pr...

Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting

SEATTLE, April 22 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) announced today presentation of preclinical data regarding its SCORPION(TM) multispecific therapeutic technology at the 100th Annual Meeting of the American Association of Cancer Research (AACR) in Denver. ...

Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research

Data Selected for Presentation Highlights Anti-Tumor effects of KRX-0401 (Perifosine) NEW YORK, April 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced multiple presentations of preclinical data highlighting the anti-tumor effects of KRX-0401 (perif...

Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting

DENVER and CARLSBAD, Calif., April 20 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today that Isis and its collaborators presented results on antisense inhibition of novel targets that could offer new mechanisms to treat cancer during the American Association fo...

Lab Manager Magazine and Association of Laboratory Managers (ALMA) Collaborate

Scientific publication Lab Manager Magazine has entered into a collaboration with ALMA, the Association of Laboratory Managers. Both organizations will be better able to serve their audiences of laboratory managers in industry, government and universities all over the world. ...

Genstruct to Present Results of Collaboration with Top Pharmaceutical Company at American Association for Cancer Research's Annual Meeting

DENVER and CAMBRIDGE, Mass., April 14 /PRNewswire/ -- ( AACR 100th Annual Meeting 2009 ) - Genstruct Inc. , a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies...

Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Research's 100th Annual Meeting

-- Phase 1 Data from Colorectal Cancer and Oral Picoplatin Trials To Be Presented -- SOUTH SAN FRANCISCO, Calif., April 14 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced that the Company will present ...

Cynvec to Present at New York Biotechnology Association 18th Annual Meeting

NEW YORK, April 13 /PRNewswire/ -- Cynvec LLC, a privately held biotechnology company focused on developing novel cancer therapies that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, President and Chief Executive Officer, will present at the N...

The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books

CHICAGO and ST. LOUIS, Missouri, March 31 /PRNewswire-FirstCall/ -- - Books Authored by Noted Coding Author Carol J. Buck Two of the biggest names in health care publishing, the American Medical Association (AMA) and Elsevier have announced an exclusive agreement to co-publish I...

International Soy Experts Meeting in Argentina Called by the Round Table on Responsible Soy Association (RTRS)

BUENOS AIRES, Argentina, March 30 /PRNewswire/ -- The Development Group of the international organization Round Table on Responsible Soy Association (RTRS) met in the city of Buenos Aires in order to design the final document on "Responsible Soy Principles and Criteria." (Logo: http:/...

Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact

- Shumlin Promoting Senate Bill S. 48 Today; Will Thwart Burgeoning Biotechnology Industry, Costing Jobs and Research Funds in Vermont - MONTPELIER, Vt., March 27 /PRNewswire/ -- The region's largest biotechnology association today warned that a bill under consideration by the Vermont Legi...

Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

CAMBRIDGE, Mass., March 18 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that four abstracts from the company's hepatitis C antiviral...

INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

-- Results from first low-dose cohorts plus data from subsequent higher-dose cohorts to be presented at EASL -- BRISBANE, Calif., March 18 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that an abstract from the clinical study of ITMN-191 (R7227) in combinatio...

Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

PRINCETON, N.J., March 17 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that the following clinical and preclinical abstracts are expected to be the subject of poster presentations at the Annual Meeting of the American Association for Cancer Research (AACR), being held ...

Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research

BETHESDA, Md., March 16 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of six abstracts for poster presentations at t...

PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting

BOSTON, March 5 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association (DIA) 21st Annual EuroMeeting, being held from March 23 - 25,...

New Trade Association Formed for North America Camelina Industry

Energy crop growing in prominence as viable vehicle and jet fuel feedstock GREAT FALLS, Mont., March 3 /PRNewswire/ -- Thirteen seed companies, processors and researchers of camelina have formed the first trade association focused on camelina production and processing in North America. The N...

American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications

Reviewer Finder to Speed up the Peer Review Process! COLUMBIA, S.C., Feb. 18 /PRNewswire-FirstCall/ -- Collexis Holdings Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that the American Association for Cancer Research ...

Netsmart University Announces Partner Referral Agreement With New York Association of Alcohol and Substance Abuse Providers

NEW YORK, Jan. 26 /PRNewswire/ -- Netsmart Technologies, Inc., a leading provider of enterprise-wide software and services for health and human services organizations, today announced it has entered into a partner referral agreement with the New York State Association of Alcoholism and Substance A...

Eisai Inc. and the Alzheimer's Association Announce the Winner of the C.A.R.E. Pharmacy Award

WOODCLIFF LAKE, N.J., Nov. 24 /PRNewswire/ -- Eisai Inc., in coordination with the Alzheimer's Association, announced today the recipient of the C.A.R.E. (Commitment to Alzheimer's. Recognition of Excellence.) Pharmacy Award. The C.A.R.E. Pharmacy Award acknowledges a pharmacist who has been nomi...

New Regional Biotech Association Formed

- 600+ Member Organization Will Focus on Policy and Public Affairs in New England - CAMBRIDGE, Mass., Nov. 13 /PRNewswire/ -- A non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations...

Elsevier and the Association of Southeast Asian Institutions

BANGKOK, November 13 /PRNewswire-FirstCall/ -- - Announce Winners of First Annual ASAIHL-Scopus Young Scientist Award Elsevier, the world's leading research publisher of scientific information, and the Association of Southeast Asian Institutions announced today winners of the first annual ...

Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008

Atherotech to add new apoA1 measurement and apoB:apoA1 ratio to its comprehensive cholesterol test, further identifying patients at risk of heart disease BIRMINGHAM, Ala., Nov. 6 /PRNewswire/ -- Atherotech, Inc., a cardio-diagnostic company, today announced it w...

Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference

REHOVOT, Israel and JERSEY CITY, New Jersey, November 3 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG ), a leader in the development of microRNA-based diagnostics, announced today it will present at AACR's centennial conference "Translational Cancer Medicine 2008: Bridging the...